⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL99596 | 1.00 | — | — | |
| SCHEMBL101534 | 1.00 | — | — | |
| SCHEMBL521914 | 0.97 | ALDH1A1 (0.35) | — | |
| SCHEMBL521913 | 0.97 | ALDH1A1 (0.35) | — | |
| SCHEMBL15940330 | 0.94 | — | — | |
| SCHEMBL2253133 | 0.94 | — | — | |
| SCHEMBL2253136 | 0.94 | — | — | |
| Methylamine SCHEMBL27938861 | 0.93 | ALDH1A1 (0.32) | — | |
| SCHEMBL1504345 | 0.88 | — | — | |
| SCHEMBL1504344 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 323 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250215005-A1 | PROCESS FOR PREPARATION OF RUXOLITINIB | ALIVUS LIFE SCIENCES LIMITED (IN) | 2025-07-03 | — | — | US | claimed |
| CN-119786604-A | Dispersing agent composition, electrode sheet and battery | 深圳市德方创域新能源科技有限公司 | 2025-04-08 | — | — | CN | claimed |
| EP-4525877-A1 | PROCESS FOR PREPARATION OF RUXOLITINIB | Alivus Life Sciences Limited (IN) | 2025-03-26 | — | — | EP | claimed |
| CN-119153896-B | Diaphragm and battery | 珠海冠宇动力电池有限公司 | 2025-03-18 | — | — | CN | claimed |
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | claimed |
| CN-119552093-A | Preparation method of key intermediate of poncirtinib phosphate | 济南鼎皓医药科技有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-119153895-B | Battery cell | 珠海冠宇动力电池有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-119153895-A | Battery cell | 珠海冠宇动力电池有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-119153896-A | Diaphragm and battery | 珠海冠宇动力电池有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-119143923-A | Multipolymer, preparation method thereof, polymer electrolyte and solid lithium ion battery | 北京卫蓝新能源科技股份有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-118994172-A | Preparation method of poncirtinib phosphate | 广州科锐特生物科技有限公司 | 2024-11-22 | — | — | CN | claimed |
| WO-2024184926-A1 | PROCESS FOR PREPARATION OF CHIRAL RUXOLITINIB AND SALTS THEREOF | AARTI PHARMALABS LIMITED (IN) | 2024-09-12 | — | — | WO | claimed |
| CN-117810530-A | In-situ polymerization high-voltage-resistant semi-solid electrolyte, preparation method thereof and lithium metal semi-solid battery | 四川启睿克科技有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-114805368-B | Preparation method of pontinib | 山东诺明康药物研究院有限公司 | 2023-12-01 | — | — | CN | claimed |
| WO-2023223253-A1 | PROCESS FOR PREPARATION OF RUXOLITINIB | GLENMARK LIFE SCIENCES LIMITED (IN) | 2023-11-23 | — | — | WO | claimed |
| CN-116014227-A | Composite material and preparation method thereof, composite gel electrolyte and preparation method and application thereof | 蜂巢能源科技股份有限公司 | 2023-04-25 | — | — | CN | claimed |
| CN-114805368-A | Preparation method of ruktinib | 山东诺明康药物研究院有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-105418616-B | A kind of JAK kinase inhibitors containing 4 amino-pyrazol structures and its preparation method and application | 山东大学 | 2018-01-12 | — | — | CN | claimed |
| US-12622908-B2 | Topical formulation for a JAK inhibitor | INCYTE CORPORATION (US) | 2026-05-12 | — | — | US | disclosed |
| US-4031015-A | LUBRICANTS, FUELS | THE LUBRIZOL CORPORATION (US) | 1977-06-21 | — | — | US | disclosed |